We are live on
!
Find out more
IAP
Indie Asset Partners Portfolio holdings
AUM
$87.8M
1-Year Est. Return
27.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+27.76%
3 Year Est. Return
+120.76%
5 Year Est. Return
+150.7%
10 Year Est. Return
–
AUM
$91.2M
AUM Growth
-$6.34M
(-6.5%)
Cap. Flow
-$12.1M
Cap. Flow
% of AUM
-13.25%
Top 10 Holdings %
Top 10 Hldgs %
63.91%
Holding
94
New
6
Increased
14
Reduced
37
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$472K |
| 2 |
DNP Select Income Fund
DNP
|
+$221K |
| 3 |
United Parcel Service
UPS
|
+$214K |
| 4 |
Norfolk Southern
NSC
|
+$211K |
| 5 |
FedEx
FDX
|
+$203K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$5.49M |
| 2 |
Royalty Pharma
RPRX
|
+$2.49M |
| 3 |
Eli Lilly
LLY
|
+$786K |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$535K |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$525K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.78% |
| 2 | Technology | 7.28% |
| 3 | Industrials | 3.56% |
| 4 | Consumer Discretionary | 3.22% |
| 5 | Financials | 2.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.02T
| $23.6M | 25.88% |
64,538
-2,216
| -3% | -$786K |
|
|
2
Royalty Pharma
RPRX
$25.9B
| $18.3M | 20.01% |
462,000
-59,750
| -11% | -$2.49M |
|
3
Apple
AAPL
$4.54T
| $4.72M | 5.17% |
36,297
-721
| -2% | -$103K |
|
4
Vanguard Energy ETF
VDE
$10.1B
| $2.37M | 2.6% |
19,527
-624
| -3% | -$76K |
|
|
5
Schwab US Dividend Equity ETF
SCHD
$103B
| $2.25M | 2.46% |
89,232
-21,693
| -20% | -$535K |
|
6
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
| $1.76M | 1.93% |
23,716
-3,050
| -11% | -$229K |
|
7
Amazon
AMZN
$2.92T
| $1.56M | 1.71% |
18,585
-1,155
| -6% | -$114K |
|
8
Microsoft
MSFT
$3.45T
| $1.38M | 1.51% |
5,763
| – | – |
|
9
iShares US Transportation ETF
IYT
$2.26B
| $1.27M | 1.39% |
23,784
-4,056
| -15% | -$219K |
|
10
iShares MSCI Agriculture Producers ETF
VEGI
$148M
| $1.14M | 1.25% |
26,575
-500
| -2% | -$21.6K |
|
11
First Trust Capital Strength ETF
FTCS
$7.91B
| $1.03M | 1.13% |
13,702
+75
| +0.6% | +$5.53K |
|
12
Pfizer
PFE
$143B
| $958K | 1.05% |
18,688
| – | – |
|
13
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $926K | 1.01% |
9,300
+1,000
| +12% | +$101K |
|
14
Alerian MLP ETF
AMLP
$13B
| $907K | 0.99% |
23,825
-3,000
| -11% | -$118K |
|
15
Elevance Health
ELV
$81.5B
| $859K | 0.94% |
1,674
-57
| -3% | -$28.9K |
|
|
SLY
16
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $826K | 0.91% |
10,047
-35
| -0.3% | -$2.92K |
|
17
PepsiCo
PEP
$190B
| $819K | 0.9% |
4,535
| – | – |
|
18
McDonald's
MCD
$192B
| $801K | 0.88% |
3,041
| – | – |
|
19
Northrop Grumman
NOC
$77.1B
| $753K | 0.83% |
1,380
-190
| -12% | -$99.1K |
|
20
ExxonMobil
XOM
$644B
| $743K | 0.81% |
6,736
-17
| -0.3% | -$1.82K |
|
21
Schwab US Broad Market ETF
SCHB
$43.2B
| $723K | 0.79% |
48,390
| – | – |
|
22
Schwab International Equity ETF
SCHF
$66.6B
| $706K | 0.77% |
43,832
+4
| +0% | +$62 |
|
23
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
| $706K | 0.77% |
50,792
-13,200
| -21% | -$190K |
|
|
24
DNP Select Income Fund
DNP
$4.05B
| $689K | 0.75% |
61,200
+20,250
| +49% | +$221K |
|
25
Visa
V
$684B
| $679K | 0.74% |
3,268
-23
| -0.7% | -$4.64K |
|
Similar funds
DG
XXIP
CVM
BCP
PM
PBCM
S2L
IC
Indie Asset Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Indie Asset Partners held 94 positions worth $91.2M, down 6.5% from $97.6M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Indie Asset Partners withdrew a net $12.1M in Q4 2022, closing 9 positions and reducing 37 holdings. Its most notable exit was Vanguard Short-Term Inflation-Protected Securities Index Fund, an estimated $5.49M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 48% a quarter earlier, followed by Technology and Industrials.
Against the trend, Indie Asset Partners opened a new position in Vanguard High Dividend Yield ETF worth $480K.
- Indie Asset Partners's largest Q4 2022 buy was Vanguard High Dividend Yield ETF: 4,435 shares worth $480K.
- Indie Asset Partners added most to DNP Select Income Fund in Q4 2022, an estimated $221K increase.
- Indie Asset Partners's biggest Q4 2022 reduction was Royalty Pharma, cutting an estimated $2.49M.
- Indie Asset Partners fully exited Vanguard Short-Term Inflation-Protected Securities Index Fund in Q4 2022, selling an estimated $5.49M.
- Indie Asset Partners's ten largest holdings make up 64% of its $91.2M portfolio in Q4 2022.
- Indie Asset Partners opened 6 new positions and closed 9 in Q4 2022.
- Indie Asset Partners's portfolio value fell 6.5% quarter-over-quarter to $91.2M.
Based on Indie Asset Partners's 13F filing for Q4 2022, filed 1 Feb 2023.